Revance Therapeutics shares owned by Wintrust Financial Corporation
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Wintrust Financial Corporation
from 13F filings
Historical chart of Wintrust Financial Corporation investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Wintrust Financial Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Wintrust Financial Corporation
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.1M | 234k | 8.79 |
| 2023-09-30 | $2.5M | 222k | 11.47 |
| 2023-06-30 | $4.9M | 195k | 25.31 |
| 2023-03-31 | $9.7M | 300k | 32.21 |
More positions owned by Wintrust Financial Corporation
View all positions for Wintrust Financial Corporation